Evercore ISI maintains HubSpot stock rating on revenue outlook By Investing.com

Evercore ISI reiterated an In Line rating and $350 price target on HubSpot, saying revised proxy disclosures make fiscal 2026 subscription revenue estimates look de-risked. The firm sees roughly 23-24% fiscal 2025 NNARR growth supporting about 19% fiscal 2026 subscription revenue growth, above the current Street view of 18-18.5%. Separately, multiple analysts remain constructive after HubSpot’s Spring 2026 Spotlight event, citing AI adoption and an Agentic Customer Platform pivot.

Analysis

HubSpot’s proxy update matters less for the incremental disclosure itself than for what it does to factor positioning: it reduces the probability of a 2026 estimate reset, which is the key near-term multiple overhang for premium software. In a market that has been punishing any hint of deceleration in subscription growth, even a modest de-risking of the forward guide can support a re-rating from “prove it” to “good enough,” especially when gross margin quality remains high and AI/productivity messaging is improving.

The second-order winner is the broader high-quality SaaS cohort. If investors conclude that mid-20s NNARR can still translate into high-teens next-year subscription growth, that supports the idea that demand normalization is not necessarily a straight line down. That is constructive for names with similar land-and-expand models, but it also creates dispersion: software vendors with weaker renewal cohorts or heavier AI spend without monetization will likely be viewed more harshly as capital rotates toward self-funding compounders.

The market is probably underpricing duration risk for NOW and IBM relative to HUBS. ServiceNow’s exposure to enterprise workflow budgets and IBM’s reliance on a steadier-but-slower growth narrative both make them more vulnerable if CIOs keep prioritizing near-term efficiency over net-new platform expansion. The contrarian point is that HUBS may be less of an AI beneficiary story than a pricing/packaging story: if the company can sustain growth through better monetization rather than only usage-driven AI uptake, the upside to estimates may arrive faster than consensus expects.

Near term, the best catalyst window is the next 1-2 quarters of software guidance season, where the market will test whether the proxy confidence is confirmed by bookings and cRPO trends. The main risk is that macro softness or longer sales cycles offset the implied de-risking, in which case the stock can give back quickly because the valuation still assumes continued execution. A second risk is that AI product launches remain more narrative than monetizable, which would cap multiple expansion even if growth stabilizes.

Key Decisions for Investors

• Long HUBS vs short NOW: enter on any post-earnings / sector weakness over the next 2-6 weeks; the pair favors the name with clearer forward growth de-risking and less exposure to enterprise budget scrutiny.
• Buy HUBS Jan-2026 call spreads (e.g., 250/325) on dips below $230: convex way to express re-rating if 2026 subscription growth converges toward ~19% and the market rewards visibility.
• Reduce exposure to high-multiple software with deteriorating guide quality, especially NOW, until next guidance season: the risk/reward is poor if investors continue to punish any sign of slower subscription growth.
• Use HUBS as a hedge inside SaaS baskets: overweight quality compounders with improving monetization and underweight names where AI spend is not translating into forward estimate support within 2 quarters.